Sélectionner une page
tiret-titre-horizontal-163x16

Strategic and Scientific Objectives

PUCE bleue

To create an integrated research structure dedicated to chronic and emerging infections

PUCE bleue

To ensure a multidisciplinary continuum between cognitive, translational and clinical research, with a strong connection with the Montpellier University Teaching Hospital (CHRU).

PUCE bleue

To study host-pathogens interactions at the molecular, cellular and host levels (pathogens such as HIV, HTLV-I, HPV, HCV, HBV, HSV, dengue, arboviruses, endogenous retroviruses, mycobacteria, prions and emerging infectious agents).

PUCE bleue

To establish the place of chronic infections and their control in the national and international Public Health stakes.

PUCE bleue

To include pathogenesis and control of chronic and emerging infections in national and international cognitive and interventional programs on chronic diseases and ageing.

PUCE bleue

To facilitate innovation (drug discoveries, diagnostic tools) and industrial partnerships in close vicinity with open platforms (CEMIPAI, BioCampus, …).and private companies

PUCE bleue

To stimulate international research partnerships on chronic and emerging infections, in particular with low and middle income countries (LMIC).

tiret-titre-horizontal-163x16

History

puce-grise-80x38

UMR 1058 was created in January 2011 after the merging a university research team (EA4205) dedicated to research on HIV pathogenesis, transmission and prevention with a group from the Molecular Dermatology Unit of the University Institute of Clinical Research (IURC) having a sound experience in research on viruses with mucocutaneous tropism.

puce-grise-80x38

In 2015, our field of expertise widened still when we teamed up with the EFS (French Blood Services) Transdiag team dedicated to innovation in diagnosis of infectious diseases.

puce-grise-80x38

Since January 1st, 2021, with the addition of a team of researchers et practitioners from the Antilles, we managed to extend our domain of expertise and succeeded in closing the gap by integrating field application for emerging pathogens.

puce-grise-80x38

Originally composed of 28 people it has been progressively enriched by new personnel and now counts up to around 70 members in total (including INSERM, University of Montpellier, University of the Antilles and EFS staff members).

montage-3-sites-pccei
tiret-titre-horizontal-163x16

Our activities are located on 3 sites

puce-verticale

INSERM delegation (Montpellier) where most activities are located including the central management of the unit;

puce-verticale

EFS Euromedecine (Montpellier), where are conducted studies on prion and innovative diagnostic assays on a ZRR campus;

puce-verticale

CHU Martinique & CHU Guadeloupe, where are conducted translational studies on arboviral infections and emerging pathogens.

tiret-titre-horizontal-163x16

International Collaborations

international-collaborations-map